|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 1’144.62 USD | -0.69% |
|
-5.84% | +6.52% |
| 18:39 | Novo Nordisk erhält EU-Zulassung für Wegovy-Abnehmpille | RE |
| 17:04 | Indiens Sun Pharma erhält in Südafrika Zulassung für generisches Ozempic | RE |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.69% | -5.84% | +1.37% | +26.49% | +6.52% | +48.34% | +156.03% | +394.58% | +1’327.08% | 1’028 Mrd. | |
| -1.67% | -4.79% | +6.42% | +5.08% | +21.19% | +61.63% | +57.66% | +48.95% | +103.90% | 611 Mrd. | |
| +1.39% | -2.43% | +11.28% | +18.31% | +7.92% | +32.30% | +82.89% | +110.44% | +289.43% | 432 Mrd. | |
| +0.98% | -1.40% | +1.26% | +4.16% | +0.61% | +29.49% | +23.12% | -7.05% | +29.19% | 323 Mrd. | |
| -0.34% | -3.10% | +1.48% | +3.09% | +11.31% | +27.00% | +43.66% | +45.55% | +51.84% | 277 Mrd. | |
| +1.63% | -11.76% | -4.80% | -14.90% | -8.88% | +19.72% | +23.20% | +50.56% | +179.12% | 257 Mrd. | |
| +3.39% | +2.29% | +15.74% | +31.25% | +1.63% | -23.68% | -38.33% | +20.11% | +77.76% | 217 Mrd. | |
| +0.57% | -2.66% | +2.19% | +2.86% | +9.43% | +22.45% | +57.21% | +45.23% | +119.37% | 192 Mrd. | |
| +1.49% | -2.52% | +6.52% | -5.27% | +7.87% | +21.40% | +70.88% | +93.85% | +52.76% | 161 Mrd. | |
| +1.79% | +2.93% | -4.79% | -8.96% | -0.58% | +0.59% | -30.97% | -38.25% | -32.68% | 138 Mrd. | |
| +0.37% | -3.84% | +6.40% | +8.51% | +5.72% | +3.25% | +33.89% | +139.54% | +431.31% | 121 Mrd. | |
| +2.29% | +1.49% | +3.84% | +0.88% | +8.27% | +25.78% | -5.58% | -13.39% | -23.16% | 116 Mrd. | |
| +1.01% | +1.18% | +0.95% | -5.98% | -7.81% | -7.79% | -19.01% | -12.50% | +0.83% | 104 Mrd. | |
| -0.21% | -3.18% | -2.12% | -10.07% | +5.04% | +36.65% | +45.34% | +8.97% | -7.08% | 103 Mrd. | |
| -1.56% | -6.46% | -4.32% | -16.34% | -13.53% | +3.54% | +84.09% | +68.91% | +451.85% | 73.58 Mrd. | |
| -2.87% | -3.89% | +31.40% | +17.11% | +28.91% | +74.67% | -5.00% | -5.58% | -49.19% | 55.22 Mrd. | |
| +4.89% | +3.87% | +18.58% | +2.35% | -3.47% | +0.51% | +21.00% | -4.34% | +261.39% | 53.42 Mrd. | |
| -0.73% | -2.94% | +4.05% | -5.64% | +9.37% | +21.26% | +22.86% | +39.53% | +19.45% | 51.97 Mrd. | |
| -0.31% | -1.18% | +7.19% | +1.73% | -4.16% | -1.16% | +13.42% | - | - | 42.52 Mrd. | |
| -0.36% | -13.45% | -2.71% | -16.01% | -29.59% | -10.00% | +38.05% | +62.84% | +334.25% | 37.55 Mrd. | |
| Durchschnitt | +0.58% | -4.13% | +5.00% | +1.93% | +2.79% | +19.30% | +33.72% | +55.16% | +190.39% | 219.71 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.30% | -4.99% | +4.08% | +9.19% | +6.48% | +31.30% | +64.44% | +127.15% | +407.43% |
- Börse
- Aktien
- 858560 Aktie
- Sektor Eli Lilly and Company
Wählen Sie MarketScreener Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben